Keyphrases
Glioblastoma
100%
Oncolytic Adenovirus
100%
Intranasal Delivery
100%
Intranasal Administration
80%
Tumor
40%
Glioblastoma Cells
40%
Oncolytic Virus
40%
Therapeutic Potential
20%
Mouse Model
20%
Virus
20%
Treatment Options
20%
Clinical Translation
20%
Therapeutic Strategies
20%
Tumor Burden
20%
Blood-brain Barrier
20%
Dismal Prognosis
20%
Immunofluorescence Analysis
20%
Xenograft
20%
Neoplastic Cells
20%
Non-neoplastic
20%
Primary Brain Tumor
20%
Human Trials
20%
Oncolytic Virotherapy
20%
Immunogenic Cell Death
20%
Glioblastoma Therapy
20%
Innovative Approach
20%
Immunology and Microbiology
Oncolytic Virus
100%
Oncolytic Adenovirus
100%
Virus
50%
Xenograft
50%
Cell Death
50%
Mouse Model
50%
Tumor Volume
50%
Blood Brain Barrier
50%
Virotherapy
50%
Immunofluorescence
50%
Medicine and Dentistry
Glioblastoma
100%
Oncolytic Adenovirus
100%
Intranasal Drug Administration
50%
Neoplasm
37%
Oncolytic Virus
25%
Clinical Trial
12%
Virus
12%
Immunofluorescence
12%
Xenograft
12%
Blood Brain Barrier
12%
Intracranial Tumor
12%
Oncolytic Virotherapy
12%
Immunogenic Cell Death
12%
Pharmacology, Toxicology and Pharmaceutical Science
Oncolytic Adenovirus
100%
Glioblastoma
100%
Neoplasm
37%
Oncolytic Virus
25%
Mouse Model
12%
Clinical Trial
12%
Immunogenic Cell Death
12%
Intracranial Tumor
12%
Virotherapy
12%
Blood-Brain Barrier
12%